Tuesday, January 25, 2022 11:52:39 PM
Sir P
I feel you, as I also lost my mom on thanksgiving morning 2019.
It was my mom’s cancers that first got me absorbing what I could about the class of disease, ultimately finding nwbo and dcvax. I also hoped dcvax might be brought to battle my mom’s terminal condition. Alas, it was not to be due to combination of incompatible saving of her tumor and oncology department not viewing dcvax as SOC nor one of their experimental trial treatments.
I still hope dcvax and what may come along with or after dcvax will be a major benefit to humanity and provide treatments that minimize adverse side effects and maximize quality of life.
God bless our loved ones, living and passed away, and all of us!
I feel you, as I also lost my mom on thanksgiving morning 2019.
It was my mom’s cancers that first got me absorbing what I could about the class of disease, ultimately finding nwbo and dcvax. I also hoped dcvax might be brought to battle my mom’s terminal condition. Alas, it was not to be due to combination of incompatible saving of her tumor and oncology department not viewing dcvax as SOC nor one of their experimental trial treatments.
I still hope dcvax and what may come along with or after dcvax will be a major benefit to humanity and provide treatments that minimize adverse side effects and maximize quality of life.
God bless our loved ones, living and passed away, and all of us!
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
